Glades Foundations

Glades Pharmaceuticals was a specialty pharmaceutical company primarily focused on the development and commercialization of generic dermatology products. The company offered a wide range of topical treatments, including creams, ointments, and gels for conditions such as acne, dermatitis, and fungal infections. Originally a subsidiary of Stiefel Laboratories, Glades was integrated into the larger organization to bolster its portfolio of skin care solutions. Following the acquisition of Stiefel by GSK in 2009, Glades Pharmaceuticals' operations and product lines were absorbed into GSK's dermatology division. The company was well-regarded for providing cost-effective alternatives to branded dermatological therapies.